NOTE: The indication of desmopressin is varying between countries and regions; not all desmopressin formulations are approved for the treatment of neurohypophyseal diabetes insipidus in all countries. Based on unpublished BA studies (CS004, RG84063-102, 45A02/48).
Reproduced with permission from: Oiso Y, Robertson GL, Nørgaard JP, Juul KV. Clinical review: Treatment of neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 2013; 98:3958-67.
https://www.endocrine.org/journals/jcem. Copyright © 2013 The Endocrine Society.
